On December 15, the United States National Institute on Drug Abuse announced new data from the annual Monitoring the Future study led by researchers at the University of Michigan.
On December 16, a data processing error was found. This...
Online regional training for trainers (ToT) on Course 10 “Managing Medication-Assisted Treatment Programs” (30 November – 3 December 2020) of the Advanced Level of the Universal Treatment Curriculum for Substance Use Disorders (UTC training...
The third edition of NZ Drug Foundation annual report on how New Zealand is dealing with alcohol and other drugs was published in December 2020.
The aim of State of the Nation is to provide a backdrop against which we can assess the impact...
As COVID-19 becomes a “new norm” and the number of positive cases is not as high as it used to be, we still need to stay alert especially when it comes to those who are the most vulnerable to the possible negative consequences.
The...
The Global Synthetic Drugs Assessment 2020 provides an analysis of the global synthetic drugs market.
Inequality in Smoking Cessation Clinical Trials – Exclusion of Smokers with Mental Health Disorders (MHDs)
The Global Drug Survey uses an anonymous online survey to conduct the world’s biggest drug survey.
The annual GDS survey runs from the middle of November each year for approximately 6 weeks.
GDS partners with global media giants to act as...
The GDS Special Edition on COVID-19 was developed as part of a global effort to better understand the impact of the pandemic on people’s lives with a specific focus on the use of alcohol and other drugs, mental health and relationships.
Ov...
"Open Access" resources do not require a university affiliation or expensive journal subscriptions. They are available to anyone with an internet connection.
This portal, developed with input from the Hubert H. Humphrey Fellows at...
